Education
About Us
Working with TipRanks
Follow Us
Jerel Davis Insider Profile
4 Followers
Jerel Davis, Director at Repare Therapeutics, holds 0.00 shares in Turnstone Biologics Corp. (Ticker: TSBX), holds 0.00 shares in Chinook Therapeutics (Ticker: KDNY), holds 2.35M shares in Repare Therapeutics (Ticker: RPTX).
Profitable Transactions
3 out of 6 Profitable Transactions
Average Return
-23.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Jerel Davis holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Dec 13, 2022 - Dec 13, 2023
Return:+57.50%
The most profitable trade made by Jerel Davis
Jerel Davis's Trading History
Repare Therapeutics
Jan 03, 2023
Director
Uninformative Buy
―
$3.69M
Chinook Therapeutics
Aug 11, 2023
―
Uninformative Sell
―
$0.00
LENZ Therapeutics
Jul 01, 2021
Director
Uninformative Buy
―
$64.64M
Turnstone Biologics Corp.
Aug 08, 2025
―
Uninformative Sell
―
$0.00
List of latest transactions for each holding click on a transaction to see Jerel Davis's performance on stock
You May Also Like
Jerel Davis insider profile FAQ
What is the percentage of profitable transactions made by Jerel Davis?
The percentage of profitable transactions made by Jerel Davis is 50%.
What is the average return per transaction made by Jerel Davis?
The average return per transaction made by Jerel Davis is -23.60%.
What stocks does Jerel Davis hold?
Jerel Davis holds: RPTX, KDNY, LENZ, TSBX stocks.
What was Jerel Davis’s latest transaction?
Jerel Davis latest transaction was an Uninformative Sell of ―.
What was Jerel Davis's most profitable transaction?
Jerel Davis’s most profitable transaction was an Informative Sell of RPTX stock on December 13, 2022. The return on the trade was 57.50%.
What is Jerel Davis's role in Repare Therapeutics?
Jerel Davis's role in Repare Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.